Asia Pacific DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic D

Asia Pacific DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], and End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others)

The Asia Pacific DNA extraction, isolation, and purification market was valued at US$ 505.36 million in 2022 and is expected to reach US$ 1,014.29 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Rising R&D in Genomics Fuels the Asia Pacific DNA Extraction, Isolation, and Purification Market

Genomics holds significant potential for improved diagnostics and treatment of genetic diseases. Genomic DNA extraction is one of the most common procedures in the life sciences. Genomic DNA contains all of an organism's genetic and chromosomal material and encodes all of the components required for life. The emergence of cutting-edge technologies for sequencing, and assembly and analysis of sequenced data is likely to strengthen the importance of genomics in medicine and other branches of science. Thus, government and nongovernment agencies are taking initiatives to boost genomic research. The funding enables researchers to provide world-class genomic healthcare, which involves the study of people's DNA as a core job.

Asia Pacific DNA Extraction, Isolation, and Purification Market Overview

The Asia Pacific DNA extraction, isolation, and purification market is expected to record a highest CAGR during 2022-2030. Gastric cancer is the third leading cause of cancer-related deaths in China. The country accounts for more than 40% of new gastric cancer cases out of 1.09 million new cases reported globally; the disease caused ~12% of cancer-related deaths in China in 2020. According to the WCRF International, China had a significant incidence age-standardized rate of 203.8 cancer cases per 100,000, with 4,546,400 new cases in 2020. Japan has a fast-aging demographic profile. According to the Organization for Economic Co-Operation and Development (OECD), people aged 60 and above are expected to account for ~40% of the total population in Japan by 2060. Therefore, the Japanese healthcare system experiences an enormous demand for advanced medical technologies and diagnostics. Further, the country has a high cancer prevalence. According to the WCRF International, Japan had a significant incidence age-standardized rate of 282.9 cancer cases per 100,000 in 2020, with 1,017,282 new cancer cases reported that year. Recently, many big pharmaceutical and nonpharmaceutical companies have invested much time and money for genomics research in India. According to a study titled Native Americans at Higher Risk for Rare Genetic Diseases, India could be home to over 8 million people suffering from rare diseases, a collective term used to describe a spectrum of over 5,000 diseases that are usually of genetic origin. The list includes hemophilia, thalassemia, sickle cell disease, and primary immunodeficiency in children; autoimmune diseases; lysosomal storage diseases (such as Pompe disease, Hirschsprung disease, Gaucher disease, cystic fibrosis, and hemangiomas); and certain forms of muscular dystrophy. Moreover, according to a study published in 2023 in the European Journal of Human Genetics, 1,890 patients suffering from rare diseases were enrolled in the Korean Genetic Diagnosis Program for Rare Diseases (KGDP) between 2017 and 2022. This study reported that rare diseases are common in children and adolescents. Therefore, the rising cases of genetic disorders and infectious diseases favor the growth of the DNA extraction, isolation, and purification market in Asia Pacific.

Asia Pacific DNA Extraction, Isolation, and Purification Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific DNA Extraction, Isolation, and Purification Market Segmentation

The Asia Pacific DNA extraction, isolation, and purification market is segmented based on type, method, sample type, source, application, end user, and country.

Based on type, the Asia Pacific DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022.

In terms of method, the Asia Pacific DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held a larger Asia Pacific DNA extraction, isolation, and purification market share in 2022. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.

By sample type, the Asia Pacific DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022.

By source, the Asia Pacific DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held a larger Asia Pacific DNA extraction, isolation, and purification market share in 2022. The microbial segment is further subsegmented into bacteria and virus.

Based on application, the Asia Pacific DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.

By end user, the Asia Pacific DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held the largest Asia Pacific DNA extraction, isolation, and purification market share in 2022.

Based on country, the Asia Pacific DNA extraction, isolation, and purification market is categorized into China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and the Rest of Asia Pacific. China dominated the Asia Pacific DNA extraction, isolation, and purification market in 2022.

Agilent Technologies, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific DNA extraction, isolation, and purification market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific DNA extraction, isolation, and purification market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific DNA extraction, isolation, and purification market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the DNA extraction, isolation, and purification market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution